|
| 36164991 | Scope of coverage of medical genetics and genomics in pre-clerkship programs of Canadian faculties of medicine: A curriculum analysis. | Am J Med Genet A | 2023 |
| 37511640 | Canadian Healthcare Professionals' Views and Attitudes toward Risk-Stratified Breast Cancer Screening. | J Pers Med | 2023 |
| 37087438 | An exploratory cross-sectional study of the effects of ongoing relationships with accompanying patients on cancer care experience, self-efficacy, and psychological distress. | BMC Cancer | 2023 |
| 37365297 | Regulating cancer risk prediction: legal considerations and stakeholder perspectives on the Canadian context. | Hum Genet | 2023 |
| 37098506 | Problem gambling among people with first-episode psychosis: protocol for a prospective multicenter cohort study. | BMC Psychiatry | 2023 |
| 36704843 | Accompanying patients in clinical oncology teams: Reported activities and perceived effects. | Health Expect | 2023 |
| 35209930 | Women's perceptions of PERSPECTIVE: a breast cancer risk stratification e-platform. | Hered Cancer Clin Pract | 2022 |
| 35582250 | Issues associated with a hereditary risk of cancer: Knowledge, attitudes and practices of nurses in oncology settings. | Can Oncol Nurs J | 2022 |
| 36523215 | Examining interprofessional collaboration in oncogenetic service delivery models for hereditary cancers: a scoping review protocol. | BMJ Open | 2022 |
| 36031172 | Integrating hereditary breast and ovarian cancer genetic counselling and testing into mainstream clinical practice: Legal and ethical challenges. | Crit Rev Oncol Hematol | 2022 |
| 36057905 | Polygenic risk scores and risk-stratified breast cancer screening: Familiarity and perspectives of health care professionals. | Genet Med | 2022 |
| 32838822 | Survey of palliative care providers' needs, perceived roles, and ethical concerns about addressing cancer family history at the end of life. | Palliat Support Care | 2021 |
| 33713298 | Problem Gambling Associated with Aripiprazole: A Nested Case-Control Study in a First-Episode Psychosis Program. | CNS Drugs | 2021 |
| 33540785 | Women's Views on Multifactorial Breast Cancer Risk Assessment and Risk-Stratified Screening: A Population-Based Survey from Four Provinces in Canada. | J Pers Med | 2021 |
| 34442372 | Risk-Stratified Approach to Breast Cancer Screening in Canada: Women's Knowledge of the Legislative Context and Concerns about Discrimination from Genetic and Other Predictive Health Data. | J Pers Med | 2021 |
| 34575693 | Should Age-Dependent Absolute Risk Thresholds Be Used for Risk Stratification in Risk-Stratified Breast Cancer Screening? | J Pers Med | 2021 |
| 34574919 | Cross-Cultural Adaptation and Validation of a French Version of the Genetic Counseling Satisfaction Scale (GCSS) as an Outcome Measure of Genetic Counseling for Hereditary Breast and Ovarian Cancer. | Healthcare (Basel) | 2021 |
| 34072979 | A Collaborative Model to Implement Flexible, Accessible and Efficient Oncogenetic Services for Hereditary Breast and Ovarian Cancer: The C-MOnGene Study. | Cancers (Basel) | 2021 |
| 34174888 | Whether, when, how, and how much? General public's and cancer patients' views about the disclosure of genomic secondary findings. | BMC Med Genomics | 2021 |
| 34199804 | Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I). | J Pers Med | 2021 |
| 33446153 | Correction to: The patient advisor, an organizational resource as a lever for an enhanced oncology patient experience (PAROLEonco): a longitudinal multiple case study protocol. | BMC Health Serv Res | 2021 |
| 31527859 | What do cancer patients' relatives think about addressing cancer family history and performing genetic testing in palliative care? | Eur J Hum Genet | 2020 |
| 32205070 | Development of a community pharmacy-based intervention to enhance adherence to adjuvant endocrine therapy among breast cancer survivors guided by the Intervention Mapping approach. | Res Social Adm Pharm | 2020 |
| 31023160 | Addressing cancer family history at the end of life: How frequent, relevant, and feasible is it? A survey of palliative care providers. | Palliat Med | 2019 |
| 30810870 | A response to "Personalised medicine and population health: breast and ovarian cancer". | Hum Genet | 2019 |
| 27804029 | Development of a Tool to Guide Parents Carrying a BRCA1/2 Mutation Share Genetic Results with Underage Children. | J Cancer Educ | 2018 |
| 30111980 | What characterizes cancer family history collection tools? A critical literature review. | Curr Oncol | 2018 |
| 29487071 | Disentangling the determinants of interest and willingness-to-pay for breast cancer susceptibility testing in the general population: a cross-sectional Web-based survey among women of Québec (Canada). | BMJ Open | 2018 |
| 28916957 | Perspectives of Women Considering Bilateral Prophylactic Mastectomy and their Peers towards a Telephone-Based Peer Support Intervention. | J Genet Couns | 2018 |
| 28674754 | Issues related to family history of cancer at the end of life: a palliative care providers' survey. | Fam Cancer | 2018 |
| 27554086 | Do women change their breast cancer mammogram screening behaviour after BRCA1/2 testing? | Fam Cancer | 2017 |
| 29054246 | Increased Use of BRCA Mutation Test in Unaffected Women Over the Period 2004-2014 in the U.S.: Further Evidence of the "Angelina Jolie Effect"? | Am J Prev Med | 2017 |
| 28983318 | Breast Cancer Risk Estimation and Personal Insurance: A Qualitative Study Presenting Perspectives from Canadian Patients and Decision Makers. | Front Genet | 2017 |
| 29270046 | No evidence of excessive cancer screening in female noncarriers from <i>BRCA1/2</i> mutation-positive families. | Curr Oncol | 2017 |
| 27318890 | Usefulness of Canadian Public Health Insurance Administrative Databases to Assess Breast and Ovarian Cancer Screening Imaging Technologies for BRCA1/2 Mutation Carriers. | Can Assoc Radiol J | 2016 |
| 26540155 | Clinical follow-up and breast and ovarian cancer screening of true BRCA1/2 noncarriers: a qualitative investigation. | Genet Med | 2016 |
| 24770975 | Validating the content of a brief informational intervention to empower patients and spouses facing breast cancer: perspectives of both couple members. | J Cancer Surviv | 2014 |
| 29751390 | Systematic review of educational tools used during the BRCA1/2 genetic testing process. | Per Med | 2014 |
| 22892900 | Life events may contribute to family communication about cancer risk following BRCA1/2 testing. | J Genet Couns | 2013 |
| 23475556 | Is the psychological impact of genetic testing moderated by support and sharing of test results to family and friends? | Fam Cancer | 2013 |
| 23485718 | Development and validation of a brief screening instrument for psychosocial risk associated with genetic testing: a pan-Canadian cohort study. | BMJ Open | 2013 |
| 23501099 | [Multidisciplinary clinical management for prophylactic mastectomy: views of women from one centre in Quebec City]. | Bull Cancer | 2013 |
| 23169493 | A focus group study on breast cancer risk presentation: one format does not fit all. | Eur J Hum Genet | 2013 |
| 23242930 | Family communication following BRCA1/2 genetic testing: a close look at the process. | J Genet Couns | 2013 |
| 23340514 | Exploring resources for intrafamilial communication of cancer genetic risk: we still need to talk. | Eur J Hum Genet | 2013 |
| 21370312 | Influence of the family cluster effect on psychosocial variables in families undergoing BRCA1/2 genetic testing for cancer susceptibility. | Psychooncology | 2012 |
| 22910539 | Development of a scale for assessing respondents' perceptions of health research questionnaires (the REP-HQ Scale). | J Clin Epidemiol | 2012 |
| 22237432 | Incidence and predictors of positive and negative effects of BRCA1/2 genetic testing on familial relationships: a 3-year follow-up study. | Genet Med | 2012 |
| 22080962 | Self-reported mammography use following BRCA1/2 genetic testing may be overestimated. | Fam Cancer | 2012 |
| 20452744 | Five questions predicted long-term, severe, back-related functional limitations: evidence from three large prospective studies. | J Clin Epidemiol | 2011 |